Law Degree. Master in Law, Instituto Superior de Derecho y Economía. Partner of the Innovation and Entrepreneurship Area
Oscar specializes in innovation, entrepreneurship and intellectual and industrial property, advising companies in the technology and biotechnology sector from the conceptualization of the business project.
He advises these companies in the negotiation with investors, establishment of partner agreements, flexible remuneration plans, etc. Oscar also advises public research entities in the definition of their intellectual and industrial property policies and technology transfer processes, including the creation of spin-offs.
An expert in life sciences, technology transfer, public law, TMT and venture capital, he has extensive experience advising leading technology companies, multinationals, start-ups, entrepreneurs, universities, research centers, hospitals and governments.
Oscar has been recognized by the most prestigious international legal directories, such as Chambers and Partners, Legal 500, Leaders League and Best Lawyers in the Intellectual Property, Life Sciences, Public Law, Venture Capital and TMT practices. In the 2020 edition of Best Lawyers, Oscar was recognized as Lawyer of the Year in the Technology Law practice. He has also been highlighted as one of the most active legal advisors in the M&A and Private Equity market (TTR/Expansión).
Degree in Biochemistry. General Manager Cotec Foundation for Innovation
General Manager Cotec Foundation for Innovation. He holds a degree in Biochemistry from the University of Salamanca and a Master’s degree in Science, Technology and Society Studies from the same University. He has also completed postgraduate studies in Pharmaceutical Industry Management and Leadership in Public Management at IE and IESE Business Schools.
From 2008 to 2012 he held the position of Director General of the Cabinet of the Minister of Science and Innovation, Cristina Garmendia, exercising functions in the general coordination of the Ministry’s political action, and supervising the public agenda, parliamentary activity and relations with the media, and once this stage was over he returned as assistant to the presidency of ASEBIO, where he was general secretary during the years 2006 to 2008.
Previously, he developed his career in the field of strategic consulting in the biotechnology sector and in the public R&D system. Barrero regularly collaborates with numerous media outlets and has taught at various universities and business schools.
MD Public Health Specialist and MBA. Mentor, consultant and business angel. WA4STEAM co-founder and amateur artist. Looking to promote a “health-smarter” European society
Salomé de Cambra (SdC) holds a medical degree, specializing in Public Health and Preventive Medicine, and an MBA graduated in Columbia University. She has 30 years of experience in the health care industry and health public administration. SdC is counselor, investor and a mentor, certified mentor, coach and evaluator at various organizations such as Technocampus and EIT-Health Network.
SdC also participated in The Collider Program/ Moblie World Capital (2019-2020). During the COVID-19 crisis, she has volunteered providing accurate information in social networks, supported technological ventures and she is currently involved in various projects to improve preparedness towards potential transmisible alerts as well as the current pandemic control.
She is also a co-founder member of the Women Angels for Sciences, Technology, Engineering, Art and Mathematics association (WA4STEAM), certified board member (Cambra de Comerç de Barcelona) and participates in a number of investment forums and women business groups.
Director Tecno-med Ingenieros – Vice-president SEEIC – Medical Device Consultant
Euroengineer by FEANI (1991). Telecommunications Engineer by the UPC (1983). Member of the COIT (1983). He is currently Director of Tecno-med Ingenieros SL. specialized in health technologies.
Previously he has worked as technical director of a manufacturer of sanitary products (EYMASA), as project engineer (NTE SA) for the ESA and product engineer (Bioingenieria SA) developing electromedical equipment (1983-95). He is an expert in audits of Notified Bodies for CE marking of medical devices and expert in audits of Notified Bodies for CE marking of medical devices.
Xavier Canals is vice-president SEEIC Sociedad Esp. Electromedicina e Ingeniería Clínica and member of others such as: SEIB, IEEE, RAPS, ASQ, AAMI, AEFI, CEDEST, SEGCIB. He is also chairman of the Electromedical Standardization Subcommittee SC62/209, and member of the AEN Committee CTN111 – ISO 13485 and CTN209 Patient Safety. Scientific evaluator of ANEP – Ministry of Science and Innovation.
He teaches courses such as Master Biomedical Engineering (Health Technology Assessment and Management), and Electromedical Technician (FP). He also teaches online training ToHealth.eu
Co-founder and CEO of GlyCardial Diagnostics
PhD in Cellular and Molecular Biology, with extensive research experience in the identification of new biomarkers of cardiovascular disease and the development of new diagnostic methods.
Author of 35 scientific publications and co-inventor of 4 patents. She received the Innovators under 35 MIT Technology Review Spanish edition award for the invention that led to the incorporation of the company GlyCardial Diagnostics in 2017, and which has managed to raise more than €5M so far between private and public funding.
He has participated in several entrepreneurship programs (Caixaimpulse) and acceleration of social impact projects (Tech4Health of Ship2B Foundation). In 2019 she obtained an MBA from La Salle Ramón Llull University and the same year she received the Emprendedor XXI award (granted by CaixaBank and ENISA). In 2020 she was selected among the 21 Women Innovators by the European Commission (EU Prize for Women Innovators).
Senior Toxicologist, CEO and Founder at Innoqua
EUROTOX registered Toxicologist with experience on development of new drugs in pharmaceutical industry for more than 30 years. Demonstrated skills for the management of non-clinical safety assessment projects. Sound scientific and regulatory knowledge to conduct experimental work, and coordinate/monitor outsourced research. Ability to design nonclinical programs reaching regulatory acceptance to support the different clinical phases and application of new drugs. Expert in risk assessment of drugs, chemicals and food additives on human health and environment, as well as impurities and leachables.
He was toxicologist at Almirall Prodesfarma S.A. Involved in the toxicity assessment of new investigational drugs and the design of toxicological programs. Study director and study monitor of toxicity studies. Preparation of documentation for regulatory purposes. Responsible for the laboratory animal unit and the animal welfare.
In 2002 he was Senior toxicologist at Vita Laboratories S.A. Responsible for the non-clinical safety assessment of new investigational drugs. Responsible for designing the toxicological programs, as well as for coordinating and monitoring non-clinical studies. Preparation of documentation for regulatory purposes.
In 2010 he was toxicology consultant at Innoqua. Consultant giving advice to pharmaceutical, veterinary, chemical, and food companies on non-clinical safety programs and risk assessment for the development of investigational products. Coordination and monitoring of non-clinical toxicology and risk assessment studies. Preparation of documentation for regulatory purposes. Interaction with regulatory agencies.
And from now on he is Toxicology Consultant. CEO, Innoqua Toxicology Consultants, S.L.
Professor of Radiology, University Carlos III. Head of Experimental Medicine and Surgery, Hospital Gregorio Marañón
Manolo Desco reached the degrees of MD, MSEng and PhD, and is specialist in Nuclear Medicine. He is Professor at the Bioengineering and Aerospace Engineering Dept. of the Universidad Carlos III de Madrid and Head of Service of the Research Dept. of the Hospital General Universitario Gregorio Marañón in Madrid. He also leads the Advanced Imaging Unit at Centro Nacional de Investigaciones Cardiovascuilares (CNIC).
He has worked as medical practitioner, entrepreneur and researcher in Biomedical Engineering. His research activities have mainly addressed the field of medical imaging, including the development of advanced techniques for image acquisition (MRI, PET, etc.) and postprocessing, either for quantification, multimodality registration or computer aided diagnosis. A significant amount of work has been devoted to the development of high-performance devices for small-animal molecular imaging, used in biomedical research. Presently, most efforts are devoted to foster and support innovation and technology transfer from Hospitals.
He has supervised 15 PhD Theses, published more than 500 papers and has participated or coordinated more than 80 national / international research projects and excellence networks, for instance “Molecular and Multimodality Medical Imaging”, IM3, or the Spanish platform on Technological Innovation in Hospitals (ITEMAS).
He has authored 30 patents and several developments from his Laboratory have been transferred to the industry, becoming commercial products with worldwide distribution.
Some relevant awards received were the UNICEM prize to technological innovation (2004) and Galien prize to best research trajectory (2008) or the award to innovative researcher 2013 from the Spanish forum of innovative enterprises. He is full member of the Spanish Academy of Medicine and Surgery (2014).
Co-Founder & Managing Partner Ship2B Ventures
Maite Fibla holds a PhD in economics and is firmly convinced that impact investing is the future, which is why she works together with entrepreneurs and investors to promote startups with high social and environmental impact and profitable business models.
She began her professional career in the academic world at the Rovira y Virgili University, passing through the University of Maastricht and the UPC School, focusing her research in the field of strategy and business competitiveness.
In 2009, he made the leap from academia to the public sector with the aim of promoting entrepreneurship and impact investment by collaborating in different public-private projects. Four years later, in 2013, together with two other partners he decided to create the Ship2B Foundation, an organization that accelerates and invests in high social impact startups and has been recognized by Funcas as the best private accelerator in Spain.
In the last 7 years the Ship2B Foundation has accelerated more than 160 startups that have raised more than 59 MM€. It also has an investment vehicle of €4.5MM that has invested in 23 high impact startups in the fields of health, education, environment and vulnerable groups.
Currently, she is Co-Founder and Managing Partner of Ship2B Ventures, an impact Venture Capital firm created in late 2020 that invests in high impact social and environmental startups.
MD. CEO of Drug Development and Regulation
Independent consultant, he founded DDR (Drug Development and Regulation, located in Barcelona, Amsterdam and London, where he is the CEO and Senior Consultant. DDR provides highquality regulatory assistance to companies and institutions developing drugs and medical devices.
He was Head of Safety and Efficacy of Medicines at the European Medicines Agency (EMA) during 2005-2012, and previously held leadership positions in the biopharmaceutical industry for more than eighteen years, covering international clinical development, drug safety, pharmacovigilance, biostatistics and medical affairs.
In addition to Dr. Luria’s specialty in internal medicine, and pharmaceutical medicine and biostatistics (University Autonomous Barcelona), he has developed expertise in several specific therapeutic areas, carried out postgraduate qualification in clinical pharmacology, drug development and regulation (Tufts University School of Medicine, Boston), and he is a recognized expert on regulatory systems and benefit-risk assessment (modelling, development and methodologies).
Furthermore, he is member of the Board of Directors of the IFAPP-King’s College Postgraduate Course, Senior Visiting Lecturer at the King’s College in London and lecturer at several other academic institutions in Europe and USA. He is currently member of the advisory board of several biopharmaceutical and medical devices companies and serves as consultant and regulatory service provider to many others in Europe, Japan, US, Australia, Israel and Latin America.
Full Professor of Surgery Medical and Innovation Director Secretary of the BJS Society
Full Professor of Surgery (accredited as Professor) at the Complutense University of Madrid and Medical Director of the Hospital Clínico San Carlos, where he was Head of the Colorectal Surgery Section (2010-2016). Since 2010 he has been Director of the Innovation Unit of the San Carlos Health Research Institute (IdSSC), member of the Center for Surgical Studies of the Department of Surgery of the UCM and trustee of the San Carlos Biomedical Research Foundation, where he also serves as Vice-President.
He has been a member of the editorial board of BJS (journal formerly known as the British Journal of Surgery), joining the board of directors in April 2015. Since June 2018 he has been Secretary of the BJS Company, a “charity” from where he works together with the rest of the Executive Committee to advance and improve the training of surgeons and to spread knowledge of new and better methods of teaching and practicing surgery in all its branches, through BJS and BJS Open. Recently, he has begun coordinating the Digital Media and Innovations Editorial Board of the journal Surgery. In addition, he is on the editorial board of the Journal of Gastrointestinal Surgery, World Journal of Gastroenterology, Turkish Journal of Surgery, and European Journal of Anatomy, where he is also Social Media Editor.
His academic training was carried out at the Faculty of Medicine of the Complutense University and he obtained his PhD at the same center in 1992. He trained as a general and digestive system surgeon at the Hospital Clínico San Carlos in Madrid, with a clinical rotation at Beth Israel Hospital in Boston in 1994. After completing his residency, he joined the Department of Surgery at Beth Israel Deaconess Medical Center with his mentor, Prof. Jeffrey B. Matthews, and the Harvard Digestive Diseases Center as a Research Fellow in Surgery at Harvard Medical School.
Upon his return to Madrid, he joined the Surgery Service I of the Hospital Clínico San Carlos, where he established two units, surgical oncology and image-guided surgery, and a cellular physiology laboratory, with the support of Prof. Jesús Alvarez Fernández-Represa. Simultaneously, he obtained a position as associate professor in the Department of Surgery at UCM.
During this time, he expanded his professional activity as a visiting surgeon at Beth Israel Deaconess Medical Center (1998), Minnesota Cancer Center (1999), Cincinnati Medical Center (2002), and as a visiting professor in the Department of Surgery at Wayne State University (2008). In addition, he completed a master’s degree in health services management at the Faculty of Political and Social Sciences at UCM.
Degree in Economic Sciences. Founding partner in Crea Inversión
Partner of Crea Inversión and Closa Investment Bankers with extensive experience in the sale and purchase of companies and capital increases in the digital, real estate, health, professional services and consumer industries, where he has led and participated in numerous international operations.
He holds a degree in Economics from the UB and has completed Masters in real estate management and other disciplines. Throughout his career he has managed companies in the investment and professional services sector (GuinotPrunera and Imacity, among others). He was General Director of Economic Promotion of the Generalitat de Catalunya in the Departament d’Economia i Finances where he participated in the creation of financial and fiscal instruments and vehicles, as well as in investment operations, public-private partnerships and in attracting multinational investments. He began his professional career at Coopers&Lybrand and later spent a period of his career in the family business where he was the promoter of various business initiatives.
He is a regular trainer and lecturer on entrepreneurship, investment and competitiveness, a mentor in various programs to support entrepreneurs and a member of several boards of directors.
He has an extensive career in the non-profit sector, and is currently a trustee and board member of the Pasqual Maragall Foundation, the Barcelona Brain Research Center and Ship2B, among others, as well as a member of the Executive Committee of Barcelona Global
President & CEO at Trifermed | Adjunct Professor at The Forsyth Institute, an affiliate of Harvard School of Dental Medicine
Entrepreneur with over 27 years of experience in health, including 18 years in international and business development. As a qualified MD, he has successfully connected the two vastly disparate fields of health and business in my professional career.
After a number of years in practice and working for some pharmaceutical companies, he founded Trifermed in 2002, a business service provider specialising in digital business development for health solutions. As the CEO of the company, he transforms his knowledge and experience in health entrepreneurship into design and validation of business models, managing business projects that have so far culminated in over 150 successfully executed collaborative partnerships in the human and animal health sector.
Apart from his activity at Trifermed, he is a Adjunct Professor at the Forsyth Institute in Cambridge, MA (USA). He also lecture as Visiting Professor on some courses of Innovation, Entrepreneurship and digital business development in Healthcare (UAB, UIC, ESADE, IESE, Weill Cornell Medicine Qatar, D·Health Barcelona, among others). A frequent speaker at international congresses and mentor different programmes in public and private business and science universities.
Degree in Chemistry. Official Intellectual Property Agent. European Trademark and Design Agent
Bernabé has extensive experience in the preparation of patentability opinions, patent infringement risk and validity studies, patent license negotiation and Due Diligence, as well as patent drafting, particularly in the areas of organic chemistry and pharmaceuticals.
He frequently acts as an expert witness before Spanish courts. Bernabé started working as a lecturer at the Patent Center of the University of Barcelona (UB) in 1988. He currently combines his work at the UB with his professional activity at ZBM.
Since its creation in 2015, Bernabé is also General Director of ZBM Business Connect, a spin-off of ZBM Patents & Trademarks dedicated to the optimization of technology transfer activities of private companies and public research institutions.
He is an expert in scientific and patent searches. For more than ten years he has been the representative in Spain of STN International and Chemical Abstracts Service. Previously he was the representative of Questel-Orbit. He has published several articles on patents and patent documentation in the Spanish press and in specialized journals.
Since 1988, he has regularly lectured in patent courses organized by the Spanish Patent and Trademark Office and the University of Barcelona. He also teaches in the main Spanish master’s degree courses on industrial property, such as the Magister Lvcentinvs (University of Alicante).